Core Insights - Fortrea has appointed Agnieszka (Aggie) M. Gallagher as general counsel, responsible for the company's legal strategy and operations, succeeding J. Stillman Hanson [1][2] - Gallagher brings over 25 years of experience in the life sciences sector, having held leadership roles in various companies including Standard Biotools, Orasure Technologies, and Alnylam Pharmaceuticals [2][3] - Gallagher expressed enthusiasm about joining Fortrea during a pivotal moment and looks forward to collaborating with the global team to accelerate innovative treatments [4] Company Overview - Fortrea is a leading global contract research organization (CRO) that provides clinical development solutions to the life sciences industry, partnering with biopharmaceutical, biotechnology, medical device, and diagnostic companies [1][4] - The company offers phase I-IV clinical trial management, clinical pharmacology, and consulting services, leveraging over 30 years of experience across more than 20 therapeutic areas [4] - Fortrea operates in approximately 100 countries, delivering focused and agile solutions to its customers globally [4]
Fortrea Appoints Agnieszka Gallagher as General Counsel